The CFRI CF Community Voices Podcast

Since CFRI awarded its first CF research grant to the legendary Paul Quinton, PhD, in 1977, CFRI has provided over $10 million to support innovative research at medical and academic institutions across the United States. In this film, current and recently funded CF researchers share about their work, the importance of continued focus on CF research, and the role CFRI has played in furthering their scientific projects and the search for a CF cure.

If you watch this episode, please let us know what you think at https://www.surveymonkey.com/r/KGB7PKY

CF Community Voices is made possible through grants from Chiesi USA, Genentech, Vertex Pharmaceuticals, Gilead Sciences, and Viatris.

CFRI's Virtual 35th National CF Education Conference featured a panel discussion about the impact of CF on the siblings. Three siblings of adults with CF – Marina Gonzales, Damian Rice, and Suraj Patel – opened up about how their siblings’ disease has shaped and influenced their own lives. The panel was moderated by Deborah Menet, LCSW, a CF social worker at the Stanford CF Center.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

Dr. Melissa Putman, Assistant Professor at Harvard Medical School and an endocrinologist at Boston Children’s Hospital (BCH) and Massachusetts General Hospital (MGH), gives a comprehensive overview on the connection between cystic fibrosis and bone disease, and the various risk factors contributing to compromised bone health. She also discusses prevention and treatment options, as well as the impact of CFTR modulators on bone health. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

In the first half of this two-part session, Jacob Fraker, MSW, an adult with CF who serves in multiple roles in the state Capitol, including as a legislative aide to a California State Senator, provided an overview of the many ways in which members of our CF community can participate in advocacy efforts individually, through CFRI, and within coalitions. Part two of the session featured Diane Shader Smith, who took on the role of advocate after her daughter Mallory lost her battle with antibiotic-resistant pathogens. Diane talked about the need for new antibiotics, antifungals, and phage therapy, the PASTEUR Act, and the groups and efforts that have mobilized to respond to this health crisis. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

CFRI's Virtual 35th National CF Education Conference featured a panel discussion about the impact of CF on the siblings. Three siblings of adults with CF – Marina Gonzales, Damian Rice, and Suraj Patel – opened up about how their siblings’ disease has shaped and influenced their own lives. The panel was moderated by Deborah Menet, LCSW, a CF social worker at the Stanford CF Center.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

Dr. Melissa Putman, Assistant Professor at Harvard Medical School and an endocrinologist at Boston Children’s Hospital (BCH) and Massachusetts General Hospital (MGH), gives a comprehensive overview on the connection between cystic fibrosis and bone disease, and the various risk factors contributing to compromised bone health. She also discusses prevention and treatment options, as well as the impact of CFTR modulators on bone health. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

In the first half of this two-part session, Jacob Fraker, MSW, an adult with CF who serves in multiple roles in the state Capitol, including as a legislative aide to a California State Senator, provided an overview of the many ways in which members of our CF community can participate in advocacy efforts individually, through CFRI, and within coalitions. Part two of the session featured Diane Shader Smith, who took on the role of advocate after her daughter Mallory lost her battle with antibiotic-resistant pathogens. Diane talked about the need for new antibiotics, antifungals, and phage therapy, the PASTEUR Act, and the groups and efforts that have mobilized to respond to this health crisis. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

Raheema Arbi is a young woman living with cystic fibrosis. In her native Pakistan, those living with CF have little access to therapies and care. In this podcast, Raheema shares her personal story of resilience, and her hope that all those living with CF - regardless of country - will receive an accurate diagnosis and optimal medical care, She hopes you will watch and share her story to raise global CF awareness.

If you watch this episode, please let us know what you think at https://www.surveymonkey.com/r/KGB7PKY

CF Community Voices is made possible through grants from Chiesi USA, Genentech, Vertex Pharmaceuticals, Gilead Sciences, and Viatris.

Dr. Richard Simon, Professor Emeritus at the Division of Pulmonary and Critical Care Medicine at the University of Michigan, gives a comprehensive overview of the health challenges faced by an aging CF population. In addition to general aging symptoms such as decreasing mobility, reduced strength, and memory loss, there are CF-specific issues such as CF-related diabetes, CF-related bone disease, and gastrointestinal cancers. This presentation was part of CFRI's Virtual 35th National CF Education Conference on July 30, 2022.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.

Dr. Donald Chi, Professor and the Lloyd and Kay Chapman Endowed Chair of Oral Health at the University of Washington School of Dentistry in Seattle, WA, gives a comprehensive summary of the available scientific data on the oral health of individuals with CF. He presents information on CF-specific risk factors that can lead to poor oral health and provides information about ongoing studies aimed at understanding the links between oral and overall health in CF. This presentation was part of CFRI's Virtual 35th National CF Education Conference.

CFRI's 35th National CF Education Conference was sponsored by Vertex Pharmaceuticals, Genentech, Gilead Sciences, Chiesi USA, AbbVie, and Ionis Pharmaceuticals.